Adaptive Oxygen Therapeutic Solutions for Unique Environments

Publication ID: 24-11857627_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Oxygen Therapeutic Solutions for Unique Environments,” Published Technical Disclosure No. 24-11857627_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857627_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,627.

Summary of the Inventive Concept

This inventive concept adapts the original oxygen therapeutic approach for use in specialized, niche environments, including high-altitude, disaster relief, high-security, extreme weather conditions, and remote, off-grid settings.

Background and Problem Solved

The original patent's oxygen therapeutic approach has limitations in its applicability to specific environments where oxygen levels or medical infrastructure may be compromised. This inventive concept addresses these limitations by developing specialized solutions that adapt the oxygen therapeutic approach to these unique environments, ensuring effective treatment of glioblastoma in a broader range of scenarios.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of adaptive solutions that modify the original oxygen therapeutic approach to accommodate the specific challenges of high-altitude, disaster relief, high-security, extreme weather conditions, and remote, off-grid environments. These solutions include systems and methods that compensate for lower oxygen levels, operate in areas with limited medical infrastructure, ensure secure and isolated administration, withstand extreme weather conditions, and function independently of external power sources. The new claims describe these adaptive solutions in detail, outlining the specific components and operational parameters required for effective treatment of glioblastoma in each unique environment.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of the original oxygen therapeutic approach to address the specific challenges of specialized, niche environments. The inventive step involves the development of new systems and methods that overcome the limitations of the original patent, enabling effective treatment of glioblastoma in a broader range of scenarios.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include adaptations for other specialized environments, such as space exploration or underwater operations. Variations could also involve the use of different oxygen therapeutic agents or administration methods, such as inhaled oxygen or oral supplements.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of oncology and emergency medicine. The target market includes hospitals, clinics, and disaster relief organizations operating in specialized environments, as well as governments and private companies involved in high-security and extreme weather operations.

CPC Classifications

SectionClassGroup
A A61 A61K41/0038
A A61 A61K9/0019
A A61 A61K9/107
A A61 A61K31/02
A A61 A61K33/00
A A61 A61K39/395
A A61 A61K45/06
A A61 A61K47/10
A A61 A61K47/24
A A61 A61K47/26
A A61 A61N5/10
A A61 A61K2039/505
A A61 A61K2039/545
A A61 A61N2005/1098

Field of Art

Medical oncology and radiotherapy, specifically focused on oxygen therapeutics and cancer treatment methods, with expertise in drug delivery systems, radiation sensitization techniques, and advanced medical interventions for glioblastoma

Person of Ordinary Skill (PHOSITA) Profile

A medical professional with advanced training in oncology, radiation therapy, and pharmacological interventions, possessing knowledge of oxygen therapeutics, emulsion technologies, and cancer treatment protocols

Obviousness Rationale

A person having ordinary skill in the art would recognize that the source patent's fundamental approach to oxygen therapeutic administration can be readily adapted to various environmental contexts without requiring inventive complexity. The core methodology of perfluoropentane emulsion administration during cancer treatment remains consistent across the disclosed variations. The PTD's environmental adaptations represent predictable engineering modifications that would be apparent to a skilled practitioner seeking to extend treatment capabilities to challenging medical scenarios.

Obvious Combinations & Variations

Source Patent Element
Intravenous administration of perfluoropentane emulsion for glioblastoma treatment
PTD Variation
Portable oxygen therapeutic system for disaster relief environments
Obviousness Reasoning
Adapting the existing administration method to a portable format represents a predictable design variation addressing operational constraints, utilizing known medical device engineering principles
Source Patent Element
Fractionated radiotherapy with oxygen therapeutic
PTD Variation
High-altitude treatment protocol compensating for lower oxygen levels
Obviousness Reasoning
Modifying dosage or delivery parameters to account for environmental oxygen variations is a standard engineering approach within medical intervention design
Source Patent Element
Water emulsion of perfluoropentane at 1-5% concentration
PTD Variation
Weather-resistant enclosure for oxygen therapeutic system
Obviousness Reasoning
Protecting medical equipment from environmental conditions represents a routine engineering solution with predictable implementation strategies
Source Patent Element
Chemotherapy and radiation therapy combination
PTD Variation
High-security isolated administration environment
Obviousness Reasoning
Modifying treatment delivery context while maintaining core medical protocol represents an obvious operational adaptation
Source Patent Element
Intravenous infusion for up to 30 minutes
PTD Variation
Solar-powered off-grid treatment system
Obviousness Reasoning
Implementing alternative power solutions for medical devices is a known technical approach with predictable engineering methods
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857627, the present publication demonstrates that variations in oxygen therapeutic administration for glioblastoma treatment across diverse environmental contexts would be obvious to a person having ordinary skill in the art. The disclosed adaptations represent straightforward extensions of the source patent's fundamental methodology, employing predictable engineering modifications that do not rise to the level of non-obvious invention.

Original Patent Information

Patent NumberUS 11,857,627
TitleFractionated radiotherapy and chemotherapy with an oxygen therapeutic
Assignee(s)NuvOx Pharma LLC